Home > Research > Browse

Results for Dose-Response Relationship, Drug

Publications & Outputs

  1. Jadomycins Inhibit Type II Topoisomerases and Promote DNA Damage and Apoptosis in Multidrug-Resistant Triple-Negative Breast Cancer Cells

    Hall, S. R., Toulany, J., Bennett, L. G., Martinez-Farina, C. F., Robertson, A. W., Jakeman, D. L. & Goralski, K. B., 1/11/2017, In: Journal of Pharmacology and Experimental Therapeutics. 363, 2, p. 196-210 15 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  2. Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease

    McClean, P. L. & Holscher, C., 11/2014, In: Neuropharmacology. 86, p. 241-258 18 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review

  3. Galantamine inhibits β-amyloid aggregation and cytotoxicity

    Matharu, B., Gibson, G., Parsons, R., Huckerby, T. N., Moore, S. A., Cooper, L. J., Millichamp, R., Allsop, D. & Austen, B., 15/05/2009, In: Journal of the Neurological Sciences. 280, 1-2, p. 49-58 10 p.

    Research output: Contribution to Journal/MagazineJournal articlepeer-review